Related Experiment Video
Updated: Jul 14, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis
Thomas Quéméneur1, Françoise Martin-Nizard, Abdelmejid Kandoussi
1Department of Nephrology and Internal Medicine, Hospital of Valenciennes, Valenciennes, France.
Insights
Systemic vasculitis (SV) is linked to increased low-density lipoprotein (LDL) oxidation and reduced paraoxonase 1 (PON1) activity. This may accelerate atherosclerosis development in patients with SV.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Biochemistry
Background:
- Systemic vasculitis (SV) predisposes individuals to atherosclerosis.
- High-density lipoprotein (HDL) plays a protective role against atherosclerosis through reverse cholesterol transport and by inhibiting low-density lipoprotein (LDL) oxidation, mediated by apolipoprotein A-I (Apo-AI) and paraoxonase 1 (PON1).
Purpose of the Study:
- To investigate whether LDL oxidation is elevated in patients with SV.
- To determine if reduced PON1 activity is associated with increased LDL oxidation in SV.
Main Methods:
- Serum analysis of 33 active SV (ASV) patients, 32 remission SV (RSV) patients, and 20 healthy subjects (HS).
- Measurements included C-reactive protein (CRP), lipids, lipoproteins, apolipoproteins, PON1 activity, LDL-immune complexes (LDL-IC), and autoantibodies to oxidized-LDL (ox-LDL).
Main Results:
- CRP levels were higher in ASV patients compared to RSV and HS, correlating negatively with HDL-cholesterol and Apo-AI.
- Autoantibodies to ox-LDL and malondialdehyde-LDL were elevated in RSV patients.
- LDL-IC titers were higher in ASV patients, and PON1 activity was lower in both ASV and RSV patients compared to HS.
Conclusions:
- Inflammatory markers in SV are associated with altered lipoprotein profiles.
- This modification may lead to decreased PON1 activity, increased ox-LDL, and accelerated atherosclerosis in SV patients.
Objectives:
Because systemic vasculitis (SV) predisposes to atherosclerosis, and high-density lipoprotein (HDL) prevents atherosclerosis by "reverse cholesterol transport" and by inhibiting low-density lipoprotein (LDL) oxidation thanks to apolipoprotein A-I (Apo-AI) and paraoxonase 1 (PON1), we assessed whether LDL oxidation was increased in SV and associated with less PON1 activity.
Methods:
The sera of 33 patients with active SV (ASV), 32 in full remission of SV (RSV) and 20 healthy subjects (HS) were analyzed for C-reactive protein (CRP), high-sensitivity-CRP, lipids, lipoproteins, apolipoproteins, PON1 activity, LDL-immune complexes (LDL-IC), and auto-antibodies to oxidized-LDL (ox-LDL), and anticardiolipin antibodies.
Results:
CRP was higher in ASV than RSV and HS, and negatively correlated with HDL-cholesterol and Apo-AI. Autoantibodies to ox-LDL and highly oxidized malondialdehyde-LDL were higher in RSV than ASV and HS (P<0.05). LDL-IC titers were higher in ASV than RSV and HS (P<0.05). PON1 activity was lower in ASV and RSV than HS (P=0.02). A trend toward a negative correlation between basal PON1 activity and anti-MDA-LDL antibodies (P=0.06) was observed.
Conclusion:
Inflammatory markers in SV were associated with a modified lipoprotein profile, which could lower PON1 activity and contribute to increased ox-LDL titers and accelerated atherosclerosis development.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies